Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Ryotaro Matsumoto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-5046-0449; OpenAlex author ID A5049831296. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2020: 2 papers · 2021: 3 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: none · 2026: 4 papers

Papers 12

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
  2. Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases. Co-author DOI 10.1016/j.pan.2026.10.007↗
  3. Type I Collagen Increases Survivin Expression in Pancreatic Cancer Cells. Co-author DOI 10.1620/tjem.2026.j084↗
  4. Diabetes Trajectory and Pancreatic Cancer Detection in Patients with Diabetes: A Nationwide Survey Through Japan Diabetes Society-Certified Facilities. Co-author DOI 10.3390/cancers18182995↗
  5. Clinical features and prognostic impact of asymptomatic pancreatic cancer. Co-author DOI 10.1038/s41598-022-08083-6↗
  6. HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer. First author DOI 10.3390/cancers14020411↗
  7. Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Ce… Co-author DOI 10.3390/ijms23169275↗
  8. Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression. Co-author DOI 10.1124/jpet.121.000744↗
  9. Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study. Co-author DOI 10.3390/diagnostics11091693↗
  10. Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition. First author DOI 10.3390/ijms22041870↗
  11. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.1620/tjem.252.353↗
  12. Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct. Co-author DOI 10.1620/tjem.252.63↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsushi Masamune · 11 shared papers, 2020–2026 · strength 1.99
  2. Shin Hamada · 10 shared papers, 2020–2026 · strength 1.70
  3. Tetsuya Takikawa · 8 shared papers, 2020–2026 · strength 1.41
  4. Kazuhiro Kikuta · 7 shared papers, 2020–2026 · strength 1.24
  5. Shin Miura · 5 shared papers, 2020–2026 · strength 0.67
  6. Michiaki Unno · 4 shared papers, 2020–2026 · strength 0.56
  7. Naoki Yoshida · 4 shared papers, 2020–2022 · strength 0.44
  8. Fumiya Kataoka · 3 shared papers, 2021–2022 · strength 0.42
  9. Naoko Hozumi · 1 shared paper, 2026 · strength 0.28
  10. Shuichi Aoki · 1 shared paper, 2026 · strength 0.23
  11. Toshiaki Abe · 1 shared paper, 2026 · strength 0.23
  12. Masahiro Iseki · 2 shared papers, 2020 · strength 0.19
  13. Kei Nakagawa · 1 shared paper, 2022 · strength 0.13
  14. Toru Furukawa · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.